GlobeNewswire by notified

Festi hf.: Buy-back programme week 10

13.3.2023 09:35:00 CET | GlobeNewswire by notified

Share

In week 10 2023, Festi purchased in total 316,030 own shares for total amount of 55,851,298 ISK as follows:


WeekDateTimePurchased sharesPricePurchase priceTotal shares boughtTotal puchase price
106.3.202310:40:002.000178356.0002.254.520401.952.002
106.3.202311:12:3750017889.0002.255.020402.041.002
106.3.202311:47:073.000178534.0002.258.020402.575.002
106.3.202312:03:433.000178534.0002.261.020403.109.002
106.3.202312:25:4450.0001798.950.0002.311.020412.059.002
106.3.202312:48:594.000178712.0002.315.020412.771.002
106.3.202314:42:055.000178890.0002.320.020413.661.002
106.3.202314:53:041.000178178.0002.321.020413.839.002
106.3.202314:54:121.000178178.0002.322.020414.017.002
106.3.202314:58:183.000178534.0002.325.020414.551.002
106.3.202315:17:265.534178985.0522.330.554415.536.054
107.3.202315:32:5650.0001788.900.0002.380.554424.436.054
108.3.202313:22:2913.9501772.469.1502.394.504426.905.204
108.3.202313:35:4335.0001776.195.0002.429.504433.100.204
108.3.202315:13:123.000176528.0002.432.504433.628.204
108.3.202315:14:426.0461761.064.0962.438.550434.692.300
109.3.202310:02:3230.0001765.280.0002.468.550439.972.300
109.3.202315:08:4250.0001768.800.0002.518.550448.772.300
1010.3.202313:21:4050.000173,58.675.0002.568.550457.447.300
316.03055.851.298


The execution of the buy-back programme is in accordance with Chapter VIII of the Company Act No 2/1995, Article 5 of the Regulation of the European parliament and of the Council (EU) on Market Fraud No. 60/2021, the Commissions Delegated Regulation No. 2016/1052 and the Act on Actions against Market Fraud No. 60/2021.

Before the purchase Festi held 5,000,000 own shares or 1.60% of issued shares. Festi has now bought in total 2,568,550 own shares for 457,447,300 ISK and holds today 7,568,550 own shares or 2.42% of issued shares.This announcement of purchase of own shares is in accordance with the buy-back programme announced 6 January 2023 to Nasdaq OMX Iceland. The programme envisages the buy-back of a total of 3,000,000 own shares or 0.96% of the issued shares, with the cap of 650 million ISK purchase price.

For further information contact Magnús Kr. Ingason, CFO of Festi hf. (mki@festi.is).


To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: openbaarmaking over transparantiekennisgeving19.4.2024 18:00:00 CEST | Press release

Geachte mevrouw, meneer, Gelieve hierbij de links te vinden naar het recente persbericht van Intervest Offices & Warehouses betreffende de openbaarmaking over transparantiekennisgeving. Dear Madam, Sir, Please find hereunder the links to Intervest Offices & Warehouses’ latest press release regarding the publication of a transparency notification. Attachment NL_transparency notification_20240419

23/2024・Trifork Group AG – Shareholders approve all resolutions at the Annual General Meeting 202419.4.2024 17:34:19 CEST | Press release

Company announcement no. 23 / 2024 Schindellegi, Switzerland – 19 April 2024 Shareholders approve all resolutions at the Annual General Meeting 2024 The shareholders of Trifork Group AG (“Trifork“) today approved all resolutions proposed by the Board of Directors at Trifork’s Annual General Meeting 2024 (the “AGM“) which was held at Grabenstrasse 2, 6430 Baar, Switzerland. Dividend payment The shareholders approved the Board of Directors’ proposal to pay a gross dividend of EUR 0.10 per share (equivalent to CHF 0.10 per share) by making a payout from capital contribution reserves to the shareholders. The total gross dividend paid out amounts to CHFk 1,932, equivalent to DKKk 14,809, as calculated per the exchange rate published by the Swiss Federal Customs Administration as of 19 April 2024. The payout from capital contribution reserves is declared in CHF and paid out in DKK. Composition of the Board of Directors The shareholders re-elected Julie Galbo as Chairperson of the Board of Di

Havila Shipping ASA: Årsrapport 202319.4.2024 17:06:25 CEST | Pressemelding

Styret i Havila Shipping ASA har i dag godkjent regnskap og årsrapport for 2023 for konsern og morselskap. Resultatregnskap og balanser er i samsvar med foreløpig regnskap offentliggjort 27. februar 2024. Kontakter: Administrerende direktør Njål Sævik, +47 909 35 722 Finansdirektør Arne Johan Dale, +47 909 87 706 Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12 Vedlegg HAVI-20235967007LIEEXZXFJ8876-2023-12-31-no

Havila Shipping ASA : Annual Report 202319.4.2024 17:06:25 CEST | Press release

Today, the Board of Directors of Havila Shipping ASA has approved the financial statements for 2023 for both the Group and the parent company. The accounts are in line with preliminary accounts released on 27 February 2024. Contacts: Chief Executive Officer Njål Sævik, +47 909 35 722 Chief Financial Officer Arne Johan Dale, +47 909 87 706 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachments HAVI-20235967007LIEEXZXFJ8876-2023-12-31-no

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons19.4.2024 17:05:00 CEST | Press release

Company announcement – No. 23 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and

HiddenA line styled icon from Orion Icon Library.Eye